174 related articles for article (PubMed ID: 13679394)
1. The MHC class II beta chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal.
Khalil H; Brunet A; Saba I; Terra R; Sékaly RP; Thibodeau J
Int Immunol; 2003 Oct; 15(10):1249-63. PubMed ID: 13679394
[TBL] [Abstract][Full Text] [Related]
2. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
Khalil H; Brunet A; Thibodeau J
J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
[TBL] [Abstract][Full Text] [Related]
3. Exit of major histocompatibility complex class II-invariant chain p35 complexes from the endoplasmic reticulum is modulated by phosphorylation.
Kuwana T; Peterson PA; Karlsson L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1056-61. PubMed ID: 9448284
[TBL] [Abstract][Full Text] [Related]
4. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain.
Arunachalam B; Lamb CA; Cresswell P
Int Immunol; 1994 Mar; 6(3):439-51. PubMed ID: 8186195
[TBL] [Abstract][Full Text] [Related]
5. ER egress of invariant chain isoform p35 requires direct binding to MHCII molecules and is inhibited by the NleA virulence factor of enterohaemorrhagic Escherichia coli.
Cloutier M; Gauthier C; Fortin JS; Genève L; Kim K; Gruenheid S; Kim J; Thibodeau J
Hum Immunol; 2015 Apr; 76(4):292-6. PubMed ID: 25731712
[TBL] [Abstract][Full Text] [Related]
6. The p35 human invariant chain in transgenic mice restores mature B cells in the absence of endogenous CD74.
Genève L; Ménard C; Labrecque N; Thibodeau J
Int Immunol; 2012 Oct; 24(10):645-60. PubMed ID: 22966065
[TBL] [Abstract][Full Text] [Related]
7. The invariant chain p35 isoform promotes formation of nonameric complexes with MHC II molecules.
Cloutier M; Gauthier C; Fortin JS; Thibodeau J
Immunol Cell Biol; 2014 Jul; 92(6):553-6. PubMed ID: 24638068
[TBL] [Abstract][Full Text] [Related]
8. On the structure-function of MHC class II molecules and how single amino acid polymorphisms could alter intracellular trafficking.
Thibodeau J; Moulefera MA; Balthazard R
Hum Immunol; 2019 Jan; 80(1):15-31. PubMed ID: 30321632
[TBL] [Abstract][Full Text] [Related]
9. The human-specific invariant chain isoform Iip35 modulates Iip33 trafficking and function.
Sand KM; Landsverk OJ; Berg-Larsen A; Bakke O; Gregers TF
Immunol Cell Biol; 2014 Oct; 92(9):791-8. PubMed ID: 24983457
[TBL] [Abstract][Full Text] [Related]
10. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes.
Lamb CA; Cresswell P
J Immunol; 1992 Jun; 148(11):3478-82. PubMed ID: 1588042
[TBL] [Abstract][Full Text] [Related]
11. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain.
Triantafilou K; Triantafilou M; Wilson KM; Cherry RJ; Fernandez N
Hum Immunol; 1999 Nov; 60(11):1101-12. PubMed ID: 10600008
[TBL] [Abstract][Full Text] [Related]
12. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment.
Odorizzi CG; Trowbridge IS; Xue L; Hopkins CR; Davis CD; Collawn JF
J Cell Biol; 1994 Jul; 126(2):317-30. PubMed ID: 8034737
[TBL] [Abstract][Full Text] [Related]
13. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.
Teyton L; O'Sullivan D; Dickson PW; Lotteau V; Sette A; Fink P; Peterson PA
Nature; 1990 Nov; 348(6296):39-44. PubMed ID: 2234057
[TBL] [Abstract][Full Text] [Related]
14. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
[TBL] [Abstract][Full Text] [Related]
15. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
[TBL] [Abstract][Full Text] [Related]
16. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
17. Release of DR molecules from complexes with invariant chain through the formation of a C-terminal 25 kDa invariant chain fragment.
Demotz S; Danieli C
Mol Immunol; 1993 Dec; 30(18):1623-32. PubMed ID: 8272076
[TBL] [Abstract][Full Text] [Related]
18. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail.
Pieters J; Bakke O; Dobberstein B
J Cell Sci; 1993 Nov; 106 ( Pt 3)():831-46. PubMed ID: 8308066
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of invariant chain (Ii)-calnexin interaction results in enhanced degradation of Ii but does not prevent the assembly of alpha beta Ii complexes.
Romagnoli P; Germain RN
J Exp Med; 1995 Dec; 182(6):2027-36. PubMed ID: 7500048
[TBL] [Abstract][Full Text] [Related]
20. Truncated MHC class II cytoplasmic and transmembrane domains: effect on plasma membrane expression.
Wade WF; Khrebtukova I; Schreiber KL; McKean DJ; Wade TK
Mol Immunol; 1995 Apr; 32(6):433-46. PubMed ID: 7753052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
